CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80

CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80 was reported 658 times

CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80 is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DRAIN OF CEREBRAL SUBDURAL SPACE 1 0.3333
1 URINE ELECTROLYTES ABNORMAL 1 0.0625
2 INSTILLATION SITE COMPLICATION 1 0.0476
3 INTESTINAL VARICES HAEMORRHAGE 1 0.0333
4 UVEITIC GLAUCOMA 1 0.0263
5 SUBDURAL EMPYEMA 1 0.0185
6 SCLERAL HYPERAEMIA 12 0.0176
7 PSEUDOFOLLICULITIS 1 0.0159
8 WRONG PRODUCT PROCURED 1 0.0152
9 POST PROCEDURAL ERYTHEMA 1 0.0112
10 PRODUCT PRIMARY PACKAGING ISSUE 1 0.0089
11 EYELASH THICKENING 1 0.0083
12 EYELID OPERATION 2 0.0075
13 INSTILLATION SITE DISCOMFORT 1 0.0075
14 EYE COMPLICATION ASSOCIATED WITH DEVICE 2 0.0074
15 INSTILLATION SITE FOREIGN BODY SENSATION 1 0.0069
16 ENTROPION 1 0.0065
17 EYELID PAIN 13 0.0064
18 EYE OPERATION COMPLICATION 1 0.0061
19 EYELID INJURY 1 0.0057
20 FOREIGN BODY SENSATION IN EYES 35 0.0055
21 CATHETER SITE VESICLES 1 0.0051
22 EYELID EXFOLIATION 4 0.0051
23 ACCIDENTAL EXPOSURE TO PRODUCT PACKAGING 1 0.0042
24 JEJUNAL PERFORATION 1 0.0041
25 KERATOMILEUSIS 1 0.0039
26 EYELID CYST 1 0.0039
27 REACTION TO PRESERVATIVES 3 0.0037
28 CATHETER SITE THROMBOSIS 1 0.0036
29 CORNEAL ABRASION 5 0.0036
30 PERIORBITAL PAIN 3 0.0035
31 EYELID THICKENING 1 0.0035
32 CHALAZION 2 0.0031
33 POSTERIOR CAPSULE OPACIFICATION 1 0.0029
34 PTERYGIUM 1 0.0029
35 EYELID IRRITATION 7 0.0028
36 INADEQUATE ASEPTIC TECHNIQUE IN USE OF PRODUCT 1 0.0028
37 EYE DISCHARGE 28 0.0027
38 INSTILLATION SITE PRURITUS 1 0.0027
39 EYE IRRITATION 151 0.0026
40 CORNEAL TRANSPLANT 2 0.0026
41 TRI-IODOTHYRONINE INCREASED 1 0.0025
42 EYE PAIN 131 0.0023
43 CORNEAL DISORDER 5 0.0023
44 VULVOVAGINAL RASH 1 0.0023
45 REFLUX LARYNGITIS 1 0.0023
46 MEIBOMIAN GLAND DYSFUNCTION 1 0.0022
47 RETINAL SCAR 1 0.0022
48 EYE OPERATION 10 0.0022
49 NEOVASCULAR AGE-RELATED MACULAR DEGENERATION 3 0.0021
50 OCULAR DISCOMFORT 24 0.0021
51 PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA 1 0.0021
52 LACRIMATION DECREASED 1 0.0021
53 FOREIGN BODY IN EYE 2 0.0021
54 INTRAOCULAR LENS IMPLANT 1 0.0020
55 INSTILLATION SITE PAIN 5 0.0020
56 ASTIGMATISM 3 0.0020
57 CATARACT OPERATION COMPLICATION 1 0.0020
58 PHOTOPHOBIA 34 0.0018
59 DRY AGE-RELATED MACULAR DEGENERATION 2 0.0018
60 METAL POISONING 1 0.0017
61 LACRIMAL DISORDER 1 0.0017
62 PRURITUS ALLERGIC 2 0.0017
63 EYE BURNS 1 0.0017
64 EYE LASER SURGERY 1 0.0017
65 INSTILLATION SITE IRRITATION 2 0.0017
66 HAEMORRHAGIC DIATHESIS 6 0.0017
67 ERYTHEMA OF EYELID 9 0.0017
68 GASTROINTESTINAL POLYP HAEMORRHAGE 1 0.0017
69 LIQUID PRODUCT PHYSICAL ISSUE 12 0.0016
70 PRODUCT CONTAINER ISSUE 14 0.0016
71 POST PROCEDURAL INFLAMMATION 1 0.0016
72 EYELIDS PRURITUS 5 0.0016
73 STOMA SITE INFECTION 2 0.0015
74 OPHTHALMIC MIGRAINE 1 0.0014
75 MACULAR DEGENERATION 17 0.0014
76 FACIAL DISCOMFORT 1 0.0014
77 ABNORMAL SENSATION IN EYE 6 0.0014
78 EYELID MARGIN CRUSTING 4 0.0014
79 PRODUCT COLOUR ISSUE 7 0.0014
80 FIBROCYSTIC BREAST DISEASE 1 0.0014
81 EXCESSIVE EYE BLINKING 2 0.0014
82 CORNEAL DEPOSITS 1 0.0013
83 ARTHRITIS INFECTIVE 6 0.0013
84 MEDICAL DEVICE IMPLANTATION 2 0.0013
85 PRODUCT DROPPER ISSUE 1 0.0013
86 GROWTH OF EYELASHES 1 0.0013
87 DRY EYE 63 0.0013
88 EYE INFLAMMATION 12 0.0013
89 OCULAR VASCULAR DISORDER 1 0.0012
90 HAND-FOOT-AND-MOUTH DISEASE 1 0.0012
91 MEDICAL PROCEDURE 2 0.0012
92 DYSPHORIA 6 0.0012
93 FOOD REFUSAL 1 0.0011
94 CATARACT 66 0.0011
95 OCULAR HYPERAEMIA 52 0.0011
96 RHINALGIA 3 0.0011
97 PUNCTATE KERATITIS 1 0.0011
98 APPETITE DISORDER 7 0.0011
99 HYPERMETROPIA 1 0.0011
100 HYPERVIGILANCE 1 0.0010
101 SKIN WARM 6 0.0010
102 LACRIMATION INCREASED 31 0.0010
103 EYELID RASH 1 0.0010
104 MASTOIDITIS 1 0.0010
105 DUST ALLERGY 1 0.0010
106 HEMIANOPIA 1 0.0010
107 STOMA COMPLICATION 1 0.0010
108 BENIGN BREAST NEOPLASM 1 0.0010
109 STEROID WITHDRAWAL SYNDROME 1 0.0010
110 HYDROCELE 1 0.0009
111 PRODUCT NAME CONFUSION 1 0.0009
112 SUPERFICIAL INJURY OF EYE 1 0.0009
113 POST PROCEDURAL SWELLING 1 0.0009
114 HALO VISION 1 0.0009
115 OPTIC NERVE INJURY 1 0.0009
116 INCORRECT PRODUCT STORAGE 11 0.0008
117 ALLERGY TO CHEMICALS 1 0.0008
118 NASAL PRURITUS 1 0.0008
119 DACRYOSTENOSIS ACQUIRED 1 0.0008
120 RETINAL DISORDER 2 0.0008
121 TEMPOROMANDIBULAR JOINT SYNDROME 2 0.0007
122 MACULAR HOLE 1 0.0007
123 SKIN DEPIGMENTATION 1 0.0007
124 CALCULUS BLADDER 1 0.0007
125 PRODUCT EXPIRATION DATE ISSUE 1 0.0007
126 MULTIPLE USE OF SINGLE-USE PRODUCT 4 0.0007
127 VITREOUS FLOATERS 7 0.0007
128 AUDITORY DISORDER 1 0.0007
129 HORDEOLUM 3 0.0007
130 STOMA SITE PAIN 1 0.0007
131 APRAXIA 1 0.0007
132 EYE INJURY 2 0.0007
133 STOMA SITE HAEMORRHAGE 1 0.0006
134 PHOTOPSIA 4 0.0006
135 INCORRECT DOSE ADMINISTERED BY PRODUCT 1 0.0006
136 CYSTITIS INTERSTITIAL 1 0.0006
137 EYE PRURITUS 20 0.0006
138 EYELID PTOSIS 6 0.0006
139 PRODUCT LABEL ISSUE 4 0.0006
140 MEDICAL DEVICE REMOVAL 1 0.0006
141 EYE DISORDER 19 0.0006
142 TENDERNESS 6 0.0006
143 PRODUCT CONTAINER SEAL ISSUE 1 0.0006
144 SPINAL CORD INJURY 1 0.0006
145 PRODUCT USE COMPLAINT 9 0.0006
146 BREAST CYST 1 0.0006
147 OPHTHALMIC HERPES ZOSTER 1 0.0006
148 SUSPECTED PRODUCT QUALITY ISSUE 1 0.0005
149 METAMORPHOPSIA 1 0.0005
150 STOMA SITE ERYTHEMA 1 0.0005
151 TRAUMATIC HAEMORRHAGE 1 0.0005
152 EYE INFECTION 6 0.0005
153 PERIORBITAL SWELLING 3 0.0005
154 RETINAL OEDEMA 1 0.0005
155 REHABILITATION THERAPY 2 0.0005
156 EYELID OEDEMA 6 0.0005
157 ALLERGIC REACTION TO EXCIPIENT 1 0.0005
158 BLEPHARITIS 2 0.0005
159 SWELLING OF EYELID 3 0.0005
160 POOR QUALITY PRODUCT ADMINISTERED 5 0.0005
161 DEVICE CONNECTION ISSUE 1 0.0005
162 EYE CONTUSION 1 0.0005
163 GLAUCOMA 9 0.0005
164 OCULOGYRIC CRISIS 1 0.0005
165 EAR PAIN 9 0.0005
166 VITREOUS DETACHMENT 1 0.0005
167 VISION BLURRED 63 0.0005
168 DANDRUFF 1 0.0005
169 FACIAL PAIN 4 0.0004
170 RETINAL DETACHMENT 4 0.0004
171 EYELID DISORDER 1 0.0004
172 SINUS PAIN 1 0.0004
173 TRANSPLANT 1 0.0004
174 MEDICATION RESIDUE PRESENT 2 0.0004
175 NASAL POLYPS 2 0.0004
176 RETINAL TEAR 1 0.0004
177 SNEEZING 9 0.0004
178 VASODILATATION 1 0.0004
179 PRODUCT ADMINISTRATION ERROR 8 0.0004
180 HERNIA REPAIR 1 0.0004
181 EXFOLIATIVE RASH 1 0.0004
182 GASTROINTESTINAL STROMAL TUMOUR 1 0.0004
183 THINKING ABNORMAL 7 0.0004
184 MIGRAINE WITH AURA 1 0.0004
185 SUBDURAL HAEMORRHAGE 1 0.0004
186 STOMA SITE DISCHARGE 1 0.0004
187 THYROID NEOPLASM 1 0.0004
188 BLINDNESS UNILATERAL 5 0.0004
189 EYE SWELLING 13 0.0003
190 LIP PAIN 1 0.0003
191 RETINAL VEIN OCCLUSION 1 0.0003
192 PRODUCT LABEL CONFUSION 2 0.0003
193 STRABISMUS 1 0.0003
194 CATARACT OPERATION 2 0.0003
195 KERATITIS 1 0.0003
196 PORTAL HYPERTENSION 1 0.0003
197 ORAL PAIN 7 0.0003
198 HOSPICE CARE 3 0.0003
199 VISUAL ACUITY REDUCED 10 0.0003
200 EXPIRED PRODUCT ADMINISTERED 10 0.0003
201 EMPHYSEMA 3 0.0003
202 POLYMENORRHOEA 1 0.0003
203 BLINDNESS TRANSIENT 2 0.0003
204 BLINDNESS 11 0.0003
205 CONJUNCTIVAL HAEMORRHAGE 1 0.0003
206 CLAVICLE FRACTURE 1 0.0003
207 GINGIVAL DISORDER 1 0.0003
208 PELVIC FRACTURE 2 0.0003
209 MUSCLE RUPTURE 1 0.0003
210 THERAPY PARTIAL RESPONDER 4 0.0003
211 SKIN PAPILLOMA 1 0.0002
212 TRIGEMINAL NEURALGIA 1 0.0002
213 UPPER-AIRWAY COUGH SYNDROME 2 0.0002
214 VISUAL IMPAIRMENT 29 0.0002
215 EYE HAEMORRHAGE 3 0.0002
216 RHINITIS ALLERGIC 1 0.0002
217 ABDOMINAL HERNIA 1 0.0002
218 WOUND 6 0.0002
219 SKIN TIGHTNESS 1 0.0002
220 VAGINAL INFECTION 1 0.0002
221 PRODUCT PACKAGING ISSUE 2 0.0002
222 COELIAC DISEASE 2 0.0002
223 EXPIRED DRUG ADMINISTERED 1 0.0002
224 INFLAMMATORY MARKER INCREASED 1 0.0002
225 INJECTION SITE INFLAMMATION 1 0.0002
226 VULVOVAGINAL PRURITUS 1 0.0002
227 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 14 0.0002
228 AMMONIA INCREASED 1 0.0002
229 HIP ARTHROPLASTY 3 0.0002
230 TRISMUS 1 0.0002
231 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
232 PRODUCT DELIVERY MECHANISM ISSUE 1 0.0002
233 PRODUCT RESIDUE PRESENT 1 0.0002
234 JAW DISORDER 1 0.0002
235 ASTHENOPIA 1 0.0002
236 CHOKING SENSATION 1 0.0002
237 PRODUCT PHYSICAL CONSISTENCY ISSUE 1 0.0002
238 GASTRIC ULCER HAEMORRHAGE 1 0.0002
239 SKIN DISORDER 6 0.0002
240 DERMATITIS CONTACT 2 0.0002
241 CORONARY ARTERY BYPASS 1 0.0002
242 RHINORRHOEA 11 0.0002
243 TENSION 1 0.0002
244 HAIR COLOUR CHANGES 2 0.0002
245 PRE-EXISTING CONDITION IMPROVED 1 0.0002
246 INTESTINAL OBSTRUCTION 6 0.0002
247 BLEPHAROSPASM 1 0.0002
248 THERAPEUTIC RESPONSE CHANGED 1 0.0002
249 INTRAOCULAR PRESSURE INCREASED 2 0.0002
250 MYDRIASIS 2 0.0002
251 POLYP 1 0.0002
252 PRODUCT PREPARATION ISSUE 1 0.0002
253 DISABILITY 3 0.0002
254 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
255 WRONG PRODUCT ADMINISTERED 1 0.0001
256 UVEITIS 2 0.0001
257 EYE MOVEMENT DISORDER 1 0.0001
258 PERIPHERAL COLDNESS 2 0.0001
259 LYMPHOEDEMA 1 0.0001
260 ENCEPHALITIS 1 0.0001
261 HAIR GROWTH ABNORMAL 1 0.0001
262 OSTEOARTHRITIS 6 0.0001
263 SEASONAL ALLERGY 2 0.0001
264 VISUAL FIELD DEFECT 1 0.0001
265 ACCIDENTAL OVERDOSE 5 0.0001
266 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
267 WHEEZING 8 0.0001
268 PRODUCT AVAILABILITY ISSUE 3 0.0001
269 LOW DENSITY LIPOPROTEIN INCREASED 1 0.0001
270 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 26 0.0001
271 MULTIPLE ALLERGIES 1 0.0001
272 ANAPHYLACTIC REACTION 7 0.0001
273 PRODUCT STORAGE ERROR 11 0.0001
274 NECK PAIN 7 0.0001
275 TRANSPLANT REJECTION 1 0.0001
276 BLISTER 7 0.0001
277 INTERSTITIAL LUNG DISEASE 6 0.0001
278 PHOTOSENSITIVITY REACTION 2 0.0001
279 SECOND PRIMARY MALIGNANCY 1 0.0001
280 HEMIPLEGIA 1 0.0001
281 SENSATION OF FOREIGN BODY 1 0.0001
282 DEVICE USE ISSUE 2 0.0001
283 IMMUNOSUPPRESSION 1 0.0001
284 HEAD DISCOMFORT 2 0.0001
285 DRY SKIN 15 0.0001
286 OEDEMA 6 0.0001
287 EXOSTOSIS 1 0.0001
288 BRAIN NEOPLASM 1 0.0001
289 CONJUNCTIVITIS 2 0.0001
290 PRODUCT DISTRIBUTION ISSUE 1 0.0001
291 ARTERIOSCLEROSIS 1 0.0001
292 SQUAMOUS CELL CARCINOMA 1 0.0001
293 LEUKAEMIA 1 0.0001
294 INABILITY TO AFFORD MEDICATION 1 0.0001
295 DRY THROAT 1 0.0001
296 POOR VENOUS ACCESS 1 0.0001
297 PRODUCT ODOUR ABNORMAL 1 0.0001
298 DRUG ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
299 HALLUCINATION 7 0.0001
300 SKIN LACERATION 1 0.0001
301 MALNUTRITION 1 0.0001
302 SKIN INFECTION 1 0.0001
303 IMPAIRED DRIVING ABILITY 1 0.0001
304 CHOLECYSTECTOMY 1 0.0001
305 INTERNAL HAEMORRHAGE 1 0.0001
306 DYSPHAGIA 8 0.0001
307 DRUG INTOLERANCE 8 0.0001
308 TENDON RUPTURE 1 0.0001
309 SECRETION DISCHARGE 1 0.0001
310 PRODUCT COMPLAINT 2 0.0001
311 ROTATOR CUFF SYNDROME 1 0.0001
312 ACCIDENTAL EXPOSURE TO PRODUCT 8 0.0001
313 DIPLOPIA 2 0.0001
314 HAIR TEXTURE ABNORMAL 1 0.0001
315 HYPOAESTHESIA 11 0.0001
316 IMPAIRED GASTRIC EMPTYING 1 0.0001
317 ERYTHEMA 15 0.0001
318 CORONARY ARTERY OCCLUSION 1 0.0001
319 CONTUSION 7 0.0001
320 APHONIA 1 0.0001
321 MASS 1 0.0001
322 BURNING SENSATION 5 0.0001
323 BLOOD TEST ABNORMAL 1 0.0001
324 SKIN REACTION 1 0.0001
325 PAIN IN JAW 2 0.0001
326 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 5 0.0001
327 THERAPY INTERRUPTED 5 0.0001
328 PULMONARY ARTERIAL HYPERTENSION 1 0.0001
329 INJECTION SITE HAEMATOMA 1 0.0001
330 MUSCULOSKELETAL STIFFNESS 6 0.0001
331 SURGERY 4 0.0001
332 COLON CANCER 1 0.0001
333 IMMUNODEFICIENCY 1 0.0001
334 HYPOAESTHESIA ORAL 1 0.0001
335 JOINT SWELLING 8 0.0001
336 THERAPEUTIC RESPONSE DECREASED 4 0.0001
337 TOXIC EPIDERMAL NECROLYSIS 1 0.0001
338 PHARYNGEAL OEDEMA 1 0.0001
339 DEVICE RELATED INFECTION 1 0.0001
340 MYALGIA 11 0.0001
341 HYPERSENSITIVITY 12 0.0001
342 ANKLE FRACTURE 1 0.0001
343 FEMUR FRACTURE 2 0.0001
344 BASAL CELL CARCINOMA 1 0.0001
345 HEAD INJURY 2 0.0001
346 HALLUCINATION, AUDITORY 1 0.0001
347 LOSS OF CONSCIOUSNESS 8 0.0001
348 HIP FRACTURE 2 0.0001
349 RHEUMATOID ARTHRITIS 7 0.0001
350 CHILLS 7 0.0001
351 PERICARDITIS 1 0.0001
352 HEMIPARESIS 1 0.0001
353 PRODUCT QUALITY ISSUE 8 0.0001
354 ILLNESS 6 0.0001
355 INFLAMMATION 3 0.0001
356 MUSCULOSKELETAL DISCOMFORT 1 0.0001
357 PARANOIA 1 0.0001
358 ORTHOSTATIC HYPOTENSION 1 0.0001
359 AMENORRHOEA 1 0.0001
360 SYSTEMIC LUPUS ERYTHEMATOSUS 2 0.0001
361 CEREBRAL HAEMORRHAGE 2 0.0001
362 RESTLESS LEGS SYNDROME 1 0.0001
363 OROPHARYNGEAL PAIN 5 0.0001
364 COUGH 15 0.0001
365 DYSPNOEA EXERTIONAL 2 0.0001
366 GASTRIC ULCER 1 0.0001
367 INCORRECT DOSE ADMINISTERED 12 0.0001
368 SLEEP APNOEA SYNDROME 1 0.0001
369 GAIT DISTURBANCE 10 0.0001
370 LOWER LIMB FRACTURE 1 0.0001
371 HAEMORRHOIDS 1 0.0001
372 CHOKING 1 0.0001
373 ORAL HERPES 1 0.0001
374 SKIN FISSURES 1 0.0001
375 PRODUCT DOSE OMISSION ISSUE 15 0.0001
376 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
377 CONSTIPATION 11 0.0001
378 WEIGHT DECREASED 14 0.0001
379 DRUG INEFFECTIVE 66 0.0001
380 SPINAL FRACTURE 1 0.0000
381 FULL BLOOD COUNT DECREASED 1 0.0000
382 PRODUCT PHYSICAL ISSUE 1 0.0000
383 INJURY ASSOCIATED WITH DEVICE 1 0.0000
384 DRUG DOSE OMISSION 8 0.0000
385 ROAD TRAFFIC ACCIDENT 2 0.0000
386 DERMATITIS 1 0.0000
387 ABDOMINAL DISCOMFORT 8 0.0000
388 KNEE ARTHROPLASTY 1 0.0000
389 SKIN EXFOLIATION 4 0.0000
390 HALLUCINATION, VISUAL 1 0.0000
391 PRURITUS 18 0.0000
392 IRRITABLE BOWEL SYNDROME 1 0.0000
393 HYPOACUSIS 2 0.0000
394 SKIN CANCER 1 0.0000
395 SWELLING FACE 3 0.0000
396 PRODUCT DOSE OMISSION 3 0.0000
397 INTENTIONAL PRODUCT MISUSE 4 0.0000
398 APPLICATION SITE PAIN 1 0.0000
399 STEVENS-JOHNSON SYNDROME 1 0.0000
400 NEOPLASM MALIGNANT 3 0.0000
401 GLOSSODYNIA 1 0.0000
402 RASH PAPULAR 1 0.0000
403 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 8 0.0000
404 BLOOD CHOLESTEROL INCREASED 2 0.0000
405 DISEASE RECURRENCE 2 0.0000
406 PRODUCTIVE COUGH 2 0.0000
407 BLOOD PRESSURE FLUCTUATION 1 0.0000
408 LOCALISED INFECTION 1 0.0000
409 PRESYNCOPE 1 0.0000
410 NEURALGIA 1 0.0000
411 DYSGEUSIA 3 0.0000
412 HEART RATE INCREASED 4 0.0000
413 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
414 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
415 BLOOD PRESSURE INCREASED 6 0.0000
416 FALL 13 0.0000
417 SINUSITIS 4 0.0000
418 UNRESPONSIVE TO STIMULI 1 0.0000
419 BACK PAIN 9 0.0000
420 EXPOSURE VIA SKIN CONTACT 1 0.0000
421 RESPIRATORY TRACT INFECTION 1 0.0000
422 DEAFNESS 1 0.0000
423 PARAESTHESIA 6 0.0000
424 GASTRITIS 1 0.0000
425 BREAST CANCER FEMALE 1 0.0000
426 FEAR 1 0.0000
427 FREQUENT BOWEL MOVEMENTS 1 0.0000
428 BLOOD BILIRUBIN INCREASED 1 0.0000
429 WHITE BLOOD CELL COUNT DECREASED 4 0.0000
430 HEADACHE 23 0.0000
431 TREATMENT NONCOMPLIANCE 2 0.0000
432 HAEMOPTYSIS 1 0.0000
433 OXYGEN SATURATION DECREASED 2 0.0000
434 ASTHMA 4 0.0000
435 MUSCULAR WEAKNESS 4 0.0000
436 INTENTIONAL DOSE OMISSION 1 0.0000
437 RED BLOOD CELL COUNT DECREASED 1 0.0000
438 HERPES ZOSTER 2 0.0000
439 BALANCE DISORDER 3 0.0000
440 ABDOMINAL PAIN 8 0.0000
441 PALPITATIONS 4 0.0000
442 BONE PAIN 2 0.0000
443 NASAL CONGESTION 2 0.0000
444 LABORATORY TEST ABNORMAL 1 0.0000
445 URINARY INCONTINENCE 1 0.0000
446 APHASIA 1 0.0000
447 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
448 CORONARY ARTERY DISEASE 1 0.0000
449 INJECTION SITE RASH 1 0.0000
450 DRUG ADMINISTRATION ERROR 1 0.0000
451 NASOPHARYNGITIS 6 0.0000
452 DIZZINESS 16 0.0000
453 CARDIAC DISORDER 3 0.0000
454 PRODUCT USE ISSUE 6 0.0000
455 CYSTITIS 1 0.0000
456 HYPOTHYROIDISM 1 0.0000
457 DEVICE DIFFICULT TO USE 2 0.0000
458 VIRAL INFECTION 1 0.0000
459 DYSPNOEA 17 0.0000
460 URINARY RETENTION 1 0.0000
461 INJECTION SITE PRURITUS 2 0.0000
462 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
463 CEREBROVASCULAR ACCIDENT 5 0.0000
464 PAIN 18 0.0000
465 ASTHENIA 11 0.0000
466 GASTRIC DISORDER 1 0.0000
467 MEMORY IMPAIRMENT 4 0.0000
468 ARTHRALGIA 12 0.0000
469 NEOPLASM PROGRESSION 1 0.0000
470 RASH MACULAR 1 0.0000
471 HEART RATE DECREASED 1 0.0000
472 PLATELET COUNT DECREASED 3 0.0000
473 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
474 SKIN BURNING SENSATION 2 0.0000
475 DRUG EFFECT INCOMPLETE 1 0.0000
476 RASH 12 0.0000
477 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1 0.0000
478 PANIC ATTACK 1 0.0000
479 OFF LABEL USE 24 0.0000
480 INJECTION SITE MASS 1 0.0000
481 BRONCHITIS 2 0.0000
482 FATIGUE 21 0.0000
483 DYSARTHRIA 1 0.0000
484 UNEVALUABLE EVENT 2 0.0000
485 HOSPITALISATION 4 0.0000
486 ARTHRITIS 2 0.0000
487 INJECTION SITE BRUISING 2 0.0000
488 THROMBOSIS 2 0.0000
489 PSORIATIC ARTHROPATHY 1 0.0000
490 INJECTION SITE ERYTHEMA 3 0.0000
491 DIARRHOEA 15 0.0000
492 MALAISE 10 0.0000
493 NAUSEA 18 0.0000
494 LIVER DISORDER 1 0.0000
495 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
496 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
497 THROAT IRRITATION 1 0.0000
498 THERAPY NON-RESPONDER 1 0.0000
499 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
500 NEPHROLITHIASIS 1 0.0000
501 MUSCLE SPASMS 4 0.0000
502 TINNITUS 1 0.0000
503 SKIN DISCOLOURATION 1 0.0000
504 HYPOKALAEMIA 1 0.0000
505 COGNITIVE DISORDER 1 0.0000
506 MIGRAINE 2 0.0000
507 MULTIPLE SCLEROSIS 1 0.0000
508 INFECTION 3 0.0000
509 HYPOGLYCAEMIA 1 0.0000
510 LUNG DISORDER 1 0.0000
511 SOMNOLENCE 4 0.0000
512 CELLULITIS 1 0.0000
513 FLUSHING 2 0.0000
514 FLUID RETENTION 1 0.0000
515 HAEMOGLOBIN DECREASED 2 0.0000
516 VOMITING 9 0.0000
517 NERVOUSNESS 1 0.0000
518 HYPERTENSION 4 0.0000
519 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
520 PNEUMONIA 6 0.0000
521 RASH PRURITIC 1 0.0000
522 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
523 MEDICATION ERROR 1 0.0000
524 HYPONATRAEMIA 1 0.0000
525 URINARY TRACT INFECTION 3 0.0000
526 PRODUCT SUBSTITUTION ISSUE 1 0.0000
527 SEIZURE 2 0.0000
528 DYSPHONIA 1 0.0000
529 DISEASE PROGRESSION 2 0.0000
530 STOMATITIS 1 0.0000
531 CONDITION AGGRAVATED 5 0.0000
532 FEELING HOT 1 0.0000
533 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
534 ANAEMIA 3 0.0000
535 BLOOD CREATININE INCREASED 1 0.0000
536 BLOOD PRESSURE DECREASED 1 0.0000
537 INSOMNIA 4 0.0000
538 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
539 INJURY 1 0.0000
540 UNDERDOSE 1 0.0000
541 PAIN IN EXTREMITY 4 0.0000
542 EPISTAXIS 1 0.0000
543 INJECTION SITE SWELLING 1 0.0000
544 PERIPHERAL SWELLING 2 0.0000
545 FEELING ABNORMAL 3 0.0000
546 CARDIAC FAILURE CONGESTIVE 1 0.0000
547 PROSTATE CANCER 1 0.0000
548 CONFUSIONAL STATE 2 0.0000
549 INFLUENZA LIKE ILLNESS 1 0.0000
550 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
551 URTICARIA 2 0.0000
552 PYREXIA 4 0.0000
553 COVID-19 2 0.0000
554 TACHYCARDIA 1 0.0000
555 GASTROINTESTINAL DISORDER 1 0.0000
556 SUICIDAL IDEATION 1 0.0000
557 ADVERSE EVENT 1 0.0000
558 DEATH 9 0.0000
559 ATRIAL FIBRILLATION 1 0.0000
560 HYPOTENSION 2 0.0000
561 CHEST DISCOMFORT 1 0.0000
562 ABDOMINAL DISTENSION 1 0.0000
563 HAEMORRHAGE 1 0.0000
564 INFLUENZA 1 0.0000
565 OEDEMA PERIPHERAL 1 0.0000
566 DEHYDRATION 1 0.0000
567 INJECTION SITE PAIN 2 0.0000
568 TREMOR 1 0.0000
569 MYOCARDIAL INFARCTION 1 0.0000
570 CHEST PAIN 1 0.0000
571 ABDOMINAL PAIN UPPER 1 0.0000
572 WEIGHT INCREASED 1 0.0000
573 DEPRESSION 1 0.0000
574 DECREASED APPETITE 1 0.0000
575 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
576 ANXIETY 1 0.0000